EX-23.1 4 ex_550110.htm EXHIBIT 23.1 CONSENT OF KPMG, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex_550110.htm

 

Exhibit 23.1

 

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the use of our report dated March 31, 2023, with respect to the consolidated financial statements of Timber Pharmaceuticals, Inc., incorporated herein by reference.

 

               /s/ KPMG LLP

 

 

Short Hills, New Jersey

August 2, 2023